Drugs News and Research

RSS

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

A new methodology for rapidly measuring the level of antibiotic drug molecules in human blood serum has been developed, paving the way to applications within drug development and personalised medicine.

3 Mar 2014

First Edition: February 28, 2014

Today's headlines include reports about the latest developments for those states that are running their own health insurance exchanges and facing difficulties.

28 Feb 2014

Longer looks: A doctor struggles with new health system; how to reduce end-of-life costs; fighting cancer with aspirin

I know how lucky I am to be a patient who happens to also work in the healthcare system. ... Initially, I had to use antibiotic drops every hour. But my insurance would only cover one three-milliliter bottle every three weeks. Each bottle not covered by insurance cost me $130. ... My own experience makes me fear that for many Americans, health insurance may not necessarily equal health care. Access and cost will still remain barriers - and can be difficult to surmount for many (Dr. Helen Ouyang, 2/24)

28 Feb 2014

Researchers discover novel treatments for psoriasis that are likely to cause fewer side effects

Almost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer Research Centre (CNIO), developed genetically modified mice showing symptoms very reminiscent to psoriasis.

28 Feb 2014

Scientists develop new anti-viral drugs that may be effective against flu virus

New analysis of the influenza A virus by scientists at the University of Hertfordshire shows potential for developing new anti-viral drugs which are more likely to be universally effective against the flu virus originating from avian, swine or human virus strains.

28 Feb 2014

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

Seattle BioMed today announced that Jason Beaubien, global health and development correspondent of National Public Radio (NPR), will deliver the keynote address at the Passport to Global Health Celebration on March 5.

28 Feb 2014

Another concern related to low birth weight identified

Researchers have identified another concern related to low birth weight - a difference in how the body reacts to drugs, which may last a person's entire life and further complicate treatment of illnesses or diseases that are managed with medications.

28 Feb 2014

UCLA develops experimental treatment that eliminates acute type of leukemia in mice

A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects.

28 Feb 2014

Protein interaction network provides invaluable resource to identify targets for Huntington's disease

Researchers at the Buck Institute have identified and categorized thousands of protein interactions involving huntingtin, the protein responsible for Huntington's disease (HD). To use an analogy of a human social network, the identified proteins are like "friends" and "friends of friends" of the HD protein.

28 Feb 2014

Loyola University Medical Center offers new high-tech catheter device for treating atrial fibrillation

Loyola University Medical Center is the first hospital in Illinois to offer a new high-tech catheter device that can improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat.

28 Feb 2014

Celsion reports positive interim data from Phase 2 DIGNITY Trial of ThermoDox in RCWBC

Celsion Corporation announced today positive interim data from its ongoing open-label Phase 2 DIGNITY Trial of ThermoDox in Recurrent Chest Wall Breast Cancer.

28 Feb 2014

TSRI scientists describe severe immune overreaction caused by flu infections

Scientists at The Scripps Research Institute have mapped key elements of a severe immune overreaction—a “cytokine storm”—that can both sicken and kill patients who are infected with certain strains of flu virus.

28 Feb 2014

Vétoquinol acquires Bioniche's Animal Health business

Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million.

28 Feb 2014

Triphase's marizomib receives FDA orphan drug designation for treatment of multiple myeloma

Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.

28 Feb 2014

FSU researchers link prenatal nicotine exposure to future ADHD

Prenatal exposure to nicotine could manifest as attention deficit hyperactivity disorder in children born a generation later, according to a new study by Florida State University College of Medicine researchers.

28 Feb 2014

Scientists discover new protein that is involved in cancer, inflammation in lung tissue

Scientists from The University of Manchester - part of the Manchester Cancer Research Centre (MCRC) - have discovered a new protein that is involved in cancer and inflammation in lung tissue.

From The University of Manchester 28 Feb 2014

Medicare Part D cost-saving plan draws opposition on several fronts

Among other things, the proposal would limit the types of antidepressants -- and other kinds of drugs -- that are available to Medicare beneficiaries. Drug industry and insurer groups are lining up against the change.

27 Feb 2014

Study identifies promising target for new drugs to treat lethal form of brain cancer

A molecule in cells that shuts down the expression of genes might be a promising target for new drugs designed to treat the most frequent and lethal form of brain cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

27 Feb 2014

Ophthotech reports net loss of $20.4 million for fourth quarter 2013

Ophthotech Corporation today announced financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on the Company's business and product development programs.

27 Feb 2014

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today reported financial results for the three months and year ended December 31, 2013, and provided an update of recent corporate developments.

27 Feb 2014

Drugs News and Research

New methodology for rapid detection of antibiotics in blood paves way to drug development, personalized treatment

First Edition: February 28, 2014

Longer looks: A doctor struggles with new health system; how to reduce end-of-life costs; fighting cancer with aspirin

Researchers discover novel treatments for psoriasis that are likely to cause fewer side effects

Scientists develop new anti-viral drugs that may be effective against flu virus

NPR correspondent to deliver keynote address at Seattle Biomed's annual event

Another concern related to low birth weight identified

UCLA develops experimental treatment that eliminates acute type of leukemia in mice

Protein interaction network provides invaluable resource to identify targets for Huntington's disease

Loyola University Medical Center offers new high-tech catheter device for treating atrial fibrillation

Celsion reports positive interim data from Phase 2 DIGNITY Trial of ThermoDox in RCWBC

TSRI scientists describe severe immune overreaction caused by flu infections

Vétoquinol acquires Bioniche's Animal Health business

Triphase's marizomib receives FDA orphan drug designation for treatment of multiple myeloma

FSU researchers link prenatal nicotine exposure to future ADHD

Scientists discover new protein that is involved in cancer, inflammation in lung tissue

Medicare Part D cost-saving plan draws opposition on several fronts

Study identifies promising target for new drugs to treat lethal form of brain cancer

Ophthotech reports net loss of $20.4 million for fourth quarter 2013

Sarepta Therapeutics reports non-GAAP net loss of $29.1 million for Q4 2013

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News